Surgical resection for gastrointestinal stromal tumors (GIST): Experience on 25 patients

World Journal of Surgical Oncology

Volumn 3, Issue , 2005, Pages

  Boni, Luigi ^a   Benevento, Angelo ^a   Dionigi, Gianlorenzo ^a   Rovera, Francesca ^a   Dionigi, Renzo ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATELECTASIS; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL SURGERY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PLEURA EFFUSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SURVIVAL RATE; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; TUMOR VOLUME; WOUND INFECTION;

EID: 30544442293     PISSN: 14777819     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-3-78     Document Type: Article

References (14)

1. Trupianio J, Stewart R, Misick C, Appleman H, Goldblum J: Gastric stromal tumors, a clinicopathological study of 77 cases with correlation of features with nonaggressive and aggressive clinical behaviour. Am J Surg Path 2002, 26:705-714
2. Fletcher C, Berman J, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Learly TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW: Diagnosis of gastrointestinal stromal tumors : a consensus approach. Hum Pathol 2002, 33: 478-483
3. Miettinen M, EI-Rifai W, Sobin LH, Lasota J: Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol 2002, 33:459-465
4. DeMatteo R, Lewis JJ, Leung D, Mudan S, Woodruff J, Brennan MF: Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000, 231:51-64
5. Bilimoria M, Holtz DJ, Mirza NQ, Feig BW, Pisters PW, Patel S, Pollock RE, Benjamin RS, Papadopoulos NE, Plager C, Murphy A, Griffin JR, Burgess MA, Hunt KK: Tumor volume as a prognostic factor for sarcomatosis. Cancer 2002, 94: 2441-2446
6. Shawer LK, Slamon D, Ullrich A: Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 2002, 1:117-123
7. Pierie JP, Choudry U, Muzikansky A, Yeap BY, Souba WW, Ott MJ: The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 2001, 136:383-389
8. Di Matteo G, Pescarmona E, Peparini M, DiMatteo FM, Zeri KP, Mascagni D, Mele R, Maturo A, Redler A, DeAntoni E: Histopathological features and clinical course of the gastrointestinal stromal tumors. Hepatogastroenterol 2002, 49:1013-1016
9. Skandalakis JE, Gray SW: Smooth muscle tumors of the alimentary tract. In: Progress in clinical cancer. Grune & Stratton, New York, 1965:692-708
10. Lillemoe KD, Efron DT: Gastrointestinal stromal tumors. In Current surgical therapy. Edited by Cameron JL, Gery L. Mosby Inc, USA, 2001: 112-117
11. Shiu MH, Farr GH, Hagdu SI: Myosarcomas of the stomach: natural history, prognostic factors and management. Cancer 1982, 49:177-187
12. van Oosterom AT, Judson I, Verweij J, Stroobants S, Di Paola ED, Dimitrijevic S, Martens M, Webb A, Sciot R, Van Glabbeke M, Silberman S, Nielsen OS: Safety and efficacy of imatinib (STI-571) in metastatic gastrointestinal stromal tumors: A phase I study. Lancet 2001, 358:1421-1423
13. Joensuu H, Roberts PJ, Salomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D, Silbeman SL, Capdeville R, Dimitrijevic S, Druker B, Demetri GD: Effect of the tyrosine kinase inhibitor ST1571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001, 344:1052-1056
14. Bucher P, Villiger P, Egger JF, Buhler LH, Morel P: Management of gastrointestinal stromal tumours: from diagnosis to treatment. Swiss Med Wkly 2004,134:145-153